Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mev Dominguez-Valentin

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
European Journal of Human Genetics : EJHG|April 28, 2025
Comment on Building a hereditary cancer program in Colombia: analysis of germline pathogenic and likely pathogenic variants spectrum in a high-risk cohortMev Dominguez-Valentin
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2014
Familial colorectal cancer type X: genetic profiles and phenotypic featuresMev Dominguez-Valentin, Christina Therkildsen, Sabrina Da Silva, et al.
Cancers|January 26, 2019
Causes for Frequent Pathogenic <i>BRCA1</i> Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic DriftPål Møller, Mev Dominguez-Valentin, Einar Andreas Rødland, et al.
Journal of Medical Genetics|October 7, 2024
Commentary on <i>Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank</i>Pål Møller, Toni T Seppälä, Mev Dominguez-Valentin, et al.
Cancers|February 14, 2020
Correction: Møller, P.; et al. Causes for Frequent Pathogenic <i>BRCA1</i> Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. <i>Cancers</i> 2019, <i>11</i>, 132Pål Møller, Mev Dominguez-Valentin, Einar Andreas Rødland, et al.
The Lancet. Oncology|September 3, 2021
Towards evidence-based personalised precision medicine for Lynch syndromePål Møller, Julian R Sampson, Mev Dominguez-Valentin, et al.
Familial Cancer|June 9, 2020
Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)Toni T Seppälä, Mev Dominguez-Valentin, Julian R Sampson, et al.
Urology|September 20, 2015
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 MutationsPatrick Joost, Christina Therkildsen, Mev Dominguez-Valentin, et al.
Frontiers in Oncology|January 5, 2023
Editorial: Advances in genetics and molecular diagnosis in colorectal, stomach, and pancreatic cancerCarlos Alberto Vaccaro, Julieta Soarez, Mev Dominguez-Valentin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2019
Response to Tolva et alJulian R Sampson, Mev Dominguez-Valentin, Toni T Seppälä, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Human Genetics : EJHG|April 28, 2025
Comment on Building a hereditary cancer program in Colombia: analysis of germline pathogenic and likely pathogenic variants spectrum in a high-risk cohortMev Dominguez-Valentin
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2014
Familial colorectal cancer type X: genetic profiles and phenotypic featuresMev Dominguez-Valentin, Christina Therkildsen, Sabrina Da Silva, et al.
Cancers|January 26, 2019
Causes for Frequent Pathogenic <i>BRCA1</i> Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic DriftPål Møller, Mev Dominguez-Valentin, Einar Andreas Rødland, et al.
Journal of Medical Genetics|October 7, 2024
Commentary on <i>Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank</i>Pål Møller, Toni T Seppälä, Mev Dominguez-Valentin, et al.
Cancers|February 14, 2020
Correction: Møller, P.; et al. Causes for Frequent Pathogenic <i>BRCA1</i> Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. <i>Cancers</i> 2019, <i>11</i>, 132Pål Møller, Mev Dominguez-Valentin, Einar Andreas Rødland, et al.
The Lancet. Oncology|September 3, 2021
Towards evidence-based personalised precision medicine for Lynch syndromePål Møller, Julian R Sampson, Mev Dominguez-Valentin, et al.
Familial Cancer|June 9, 2020
Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)Toni T Seppälä, Mev Dominguez-Valentin, Julian R Sampson, et al.
Urology|September 20, 2015
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 MutationsPatrick Joost, Christina Therkildsen, Mev Dominguez-Valentin, et al.
Frontiers in Oncology|January 5, 2023
Editorial: Advances in genetics and molecular diagnosis in colorectal, stomach, and pancreatic cancerCarlos Alberto Vaccaro, Julieta Soarez, Mev Dominguez-Valentin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2019
Response to Tolva et alJulian R Sampson, Mev Dominguez-Valentin, Toni T Seppälä, et al.
Pageof 8